Sale of BASF's pharmaceutical business to Abbott completed
BASF, Ludwigshafen, Germany, today, March 2, 2001, completed the sale of its pharmaceutical business for $6.9 billion to Abbott Laboratories, Abbott Park, Illinois following full regulatory approval. The sale will enable BASF to concentrate better on the strengths in its portfolio and achieve further profitable growth.
Eggert Voscherau, a member of BASF's Board of Executive Directors, said: "The timing of the transaction has been ideal for all parties. The excellent cooperation with Abbott is a sign off how well BASF Pharma fits into its new business setting."
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.